BusinessA New Audio Interview with James Nathanielsz, Propanc Biopharma Inc.'s Chief Executive Officer, is now at SmallCapVoice.comBy Nasdaq OMXMay 23, 2017, 12:08 PM UTC
BusinessMyriad Genetics to Present Seven Studies at the 2017 American Society of Clinical Oncology Annual MeetingBy Nasdaq OMXMay 18, 2017, 11:06 AM UTC
BusinessData from Clinical Study of NewLink Genetics’ IDO Pathway Inhibitor, Indoximod, to Be Presented at the 22nd European Hematology Association CongressBy Nasdaq OMXMay 18, 2017, 10:03 AM UTC
BusinessData from Clinical Study of NewLink Genetics’ IDO Pathway Inhibitor, Indoximod, to Be Presented at the 22nd European Hematology Association CongressBy Nasdaq OMXMay 18, 2017, 10:03 AM UTC
BusinessData from Clinical Study of NewLink Genetics’ IDO Pathway Inhibitor, Indoximod, to Be Presented at the 22nd European Hematology Association CongressBy Nasdaq OMXMay 18, 2017, 10:03 AM UTC
BusinessData from Clinical Study of NewLink Genetics’ IDO Pathway Inhibitor, Indoximod, to Be Presented at the 22nd European Hematology Association CongressBy Nasdaq OMXMay 18, 2017, 10:03 AM UTC
BusinessAmarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular CareBy Nasdaq OMXMay 18, 2017, 10:01 AM UTC
BusinessAmarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular CareBy Nasdaq OMXMay 18, 2017, 10:01 AM UTC
